Oric Pharmaceuticals, Inc. ORIC Total debt

Total debt at other companies

PfizerPFE

$64.43B+4.9%

ArriVent BioPharma, Inc.AVBP

$419K+204%

CG OncologyCGON

$8.82M+787%

Olema Pharmaceuticals, Inc.OLMA

$956K-16.7%

Stoke Therapeutics, Inc.STOK

$3.42M-42.5%

NTH

Neonc Technologies HoldingsNTHI

$648.22K+63.9%

FAQ

What is Oric Pharmaceuticals, Inc.'s total debt?

Oric Pharmaceuticals, Inc. (ORIC) reported total debt of $3.3M in Q1 2026.

How has Oric Pharmaceuticals, Inc.'s total debt changed year-over-year?

Oric Pharmaceuticals, Inc.'s total debt increased by 2.6% year-over-year, from $3.21M to $3.3M.

What is the long-term trend for Oric Pharmaceuticals, Inc.'s total debt?

Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s total debt has grown at a -12.1% compound annual growth rate (CAGR), from $12.44M to $7.44M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.